{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:04:20Z","timestamp":1785528260325,"version":"3.56.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-147093OB-I00"],"award-info":[{"award-number":["PID2023-147093OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Consejeria de Salud y Familias","award":["PI-0036-2020"],"award-info":[{"award-number":["PI-0036-2020"]}]},{"name":"Consejeria de Salud y Familias","award":["PI-0036-2020"],"award-info":[{"award-number":["PI-0036-2020"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01718"],"award-info":[{"award-number":["PI22\/01718"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01718"],"award-info":[{"award-number":["PI22\/01718"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Interest in the study of type 1 diabetes mellitus (T1DM) and multiple sclerosis (MS) has increased because of their significant negative impact on the patient quality of life and the profound implications for the health care system. Although the clinical symptoms of T1DM differ from those of MS, such as pancreatic \u03b2-cell failure in T1DM and demyelination in the central nervous system (CNS) in MS, both pathologies are considered as autoimmune-related diseases with shared pathogenic pathways, which include autophagy, inflammation and degeneration, among others. Considering the challenges in obtaining pancreatic \u03b2-cells and CNS tissue from patients with T1DM and MS, respectively, it is fundamental to explore alternative methods for evaluating disease status. Proteomic analysis of peripheral blood mononuclear cells (PBMCs) is an ideal approach for identifying novel and potential biomarkers for both autoimmune diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a proteomic analysis of PBMCs from patients with T1DM and relapsing remitting Multiple Sclerosis (herein forth MS) patients (n\u2009=\u20099 per condition), using a label-free quantitative proteomics approach. The patients were diagnosed following the American Diabetes Association (ADA) criteria for T1DM and McDonald criteria for MS respectively, and were aged over 18\u00a0years and more than 2\u00a0years from the onset respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 2476 proteins were differentially expressed in PBMCs from patients with T1DM and MS patients compared with those form healthy controls (H). Predictive analysis highlighted 15 common proteins, up- or downregulated in PBMCs from patients with T1DM and MS patients <jats:italic>vs.<\/jats:italic> healthy controls, involved in the immune system activity (BTF3, TTR, CD59, CSTB), diseases of the neuronal system (TTR), signal transduction (STMN1, LAMTOR5), metabolism of nucleotides (RPS21), proteins (TTR, ENAM, CD59, RPS21, SRP9) and RNA (SRSF10, RPS21). In addition, this study revealed both shared and distinct molecular patterns between the two conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Compared with H, patients with T1DM and MS presented a specific expression pattern of common proteins has been identified. This pattern underscores the shared mechanisms involved in their immune responses and neurological complications, alongside dysregulation of the autophagy pathway. Notably, CSTB has emerged as a differential biomarker, distinguishing between these two autoimmune diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s10020-025-01084-x","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T04:28:41Z","timestamp":1738556921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring proteomic immunoprofiles: common neurological and immunological pathways in multiple sclerosis and type 1 diabetes mellitus"],"prefix":"10.1186","volume":"31","author":[{"given":"F\u00e1tima","family":"Cano-Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Lara-Barea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro Javier","family":"Cruz-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mart\u00edn-Loro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"G\u00f3mez-Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carmen","family":"Gonz\u00e1lez-Montelongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Mar","family":"Roca-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Beltr\u00e1n-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Forero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier J.","family":"Gonz\u00e1lez-Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Carmen","family":"Dur\u00e1n-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Arroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Aguilar-Diosdado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"1084_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15548627.2023.2259281","volume":"20","author":"HM Al-kuraishy","year":"2024","unstructured":"Al-kuraishy HM, Jabir MS, Al-Gareeb AI, Saad HM, Batiha GES, Klionsky DJ. The beneficial role of autophagy in multiple sclerosis: yes or no? Autophagy. 2024;20:259\u201374. https:\/\/doi.org\/10.1080\/15548627.2023.2259281.","journal-title":"Autophagy"},{"key":"1084_CR2","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1038\/s41598-020-60699-8","volume":"10","author":"B Alshehri","year":"2020","unstructured":"Alshehri B, Pagnin M, Lee JY, Petratos S, Richardson SJ. The role of transthyretin in oligodendrocyte development. Sci Rep. 2020;10:4189. https:\/\/doi.org\/10.1038\/s41598-020-60699-8.","journal-title":"Sci Rep"},{"key":"1084_CR3","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1093\/nar\/gkt563","volume":"41","author":"W B\u2019chir","year":"2013","unstructured":"B\u2019chir W, Maurin A-C, Carraro V, Averous J, Jousse C, Muranishi Y, Parry L, Stepien G, Fafournoux P, Bruhat A. The eIF2\u03b1\/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013;41:7683\u201399. https:\/\/doi.org\/10.1093\/nar\/gkt563.","journal-title":"Nucleic Acids Res"},{"key":"1084_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ANA.21244","volume":"63","author":"B Banwell","year":"2008","unstructured":"Banwell B, Bar-Or A, Cheung R, Kennedy J, Krupp LB, Becker DJ, Dosch HM. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes. Ann Neurol. 2008;63:98\u2013111. https:\/\/doi.org\/10.1002\/ANA.21244.","journal-title":"Ann Neurol"},{"key":"1084_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2337\/dc13-1414","volume":"37","author":"S Bechtold","year":"2014","unstructured":"Bechtold S, Blaschek A, Raile K, Dost A, Freiberg C, Askenas M, Fr\u00f6hlich-Reiterer E, Molz E, Holl RW. Higher relative risk for multiple sclerosis in a pediatric and adolescent diabetic population: analysis from DPV database. Diabetes Care. 2014;37:96\u2013101. https:\/\/doi.org\/10.2337\/dc13-1414.","journal-title":"Diabetes Care"},{"key":"1084_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/intimm\/dxs049","volume":"24","author":"D Bending","year":"2012","unstructured":"Bending D, Zaccone P, Cooke A. Inflammation and type one diabetes. Int Immunol. 2012;24:339\u201346. https:\/\/doi.org\/10.1093\/intimm\/dxs049.","journal-title":"Int Immunol"},{"key":"1084_CR7","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/eji.201545955","volume":"46","author":"Y Botbol","year":"2016","unstructured":"Botbol Y, Guerrero-Ros I, Macian F. Key roles of autophagy in regulating T-cell function. Eur J Immunol. 2016;46:1326\u201334. https:\/\/doi.org\/10.1002\/eji.201545955.","journal-title":"Eur J Immunol"},{"key":"1084_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.nbd.2009.11.014","volume":"37","author":"B Brynedal","year":"2010","unstructured":"Brynedal B, Khademi M, Wallstr\u00f6m E, Hillert J, Olsson T, Duvefelt K. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery? Neurobiol Dis. 2010;37:613\u201321. https:\/\/doi.org\/10.1016\/j.nbd.2009.11.014.","journal-title":"Neurobiol Dis"},{"key":"1084_CR9","doi-asserted-by":"publisher","first-page":"102551","DOI":"10.1016\/j.redox.2022.102551","volume":"58","author":"F Canet","year":"2022","unstructured":"Canet F, D\u00edaz-Pozo P, Luna-Marco C, Fernandez-Reyes M, Vezza T, Marti M, Salazar JD, Roldan I, Morillas C, Rovira-Llopis S, Rocha M, V\u00edctor VM. Mitochondrial redox impairment and enhanced autophagy in peripheral blood mononuclear cells from type 1 diabetic patients. Redox Biol. 2022;58:102551. https:\/\/doi.org\/10.1016\/j.redox.2022.102551.","journal-title":"Redox Biol"},{"key":"1084_CR10","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"D Care","year":"2021","unstructured":"Care D, Suppl SS. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44:S15\u201333. https:\/\/doi.org\/10.2337\/dc21-S002.","journal-title":"Diabetes Care"},{"key":"1084_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13098-020-00563-x","volume":"12","author":"D Catarino","year":"2020","unstructured":"Catarino D, Silva D, Guiomar J, Ribeiro C, Ruas L, Cardoso L, Paiva I. Non-immune-mediated versus immune-mediated type 1 diabetes: diagnosis and long-term differences\u2014retrospective analysis. Diabetol Metab Syndr. 2020;12:4\u20139. https:\/\/doi.org\/10.1186\/s13098-020-00563-x.","journal-title":"Diabetol Metab Syndr"},{"key":"1084_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.freeradbiomed.2019.07.034","volume":"143","author":"T Chatterjee","year":"2019","unstructured":"Chatterjee T, Pattanayak R, Ukil A, Chowdhury S, Bhattacharyya M. Autophagy protects peripheral blood mononuclear cells against inflammation, oxidative and nitrosative stress in diabetic dyslipidemia. Free Radic Biol Med. 2019;143:309\u201323. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.07.034.","journal-title":"Free Radic Biol Med"},{"key":"1084_CR13","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1007\/s00125-016-3929-0","volume":"59","author":"IC Chou","year":"2016","unstructured":"Chou IC, Wang CH, Lin WD, Tsai FJ, Lin CC, Kao CH. Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study. Diabetologia. 2016;59:1196\u2013203. https:\/\/doi.org\/10.1007\/s00125-016-3929-0.","journal-title":"Diabetologia"},{"key":"1084_CR14","first-page":"132","volume":"5","author":"M Cojocaru","year":"2010","unstructured":"Cojocaru M, Cojocaru IM, Silosi I. Multiple autoimmune syndrome. Maedica. 2010;5:132\u20134.","journal-title":"Maedica"},{"key":"1084_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/B978-0-444-64076-5.00046-6","volume":"148","author":"C Cotsapas","year":"2018","unstructured":"Cotsapas C, Mitrovic M, Hafler D. Multiple sclerosis. Handb Clin Neurol. 2018;148:723\u201330. https:\/\/doi.org\/10.1016\/B978-0-444-64076-5.00046-6.","journal-title":"Handb Clin Neurol"},{"key":"1084_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367\u201372. https:\/\/doi.org\/10.1038\/nbt.1511.","journal-title":"Nat Biotechnol"},{"key":"1084_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21124558","volume":"21","author":"M De Bondt","year":"2020","unstructured":"De Bondt M, Hellings N, Opdenakker G, Struyf S. Neutrophils: underestimated players in the pathogenesis of multiple sclerosis (ms). Int J Mol Sci. 2020;21:1\u201325. https:\/\/doi.org\/10.3390\/ijms21124558.","journal-title":"Int J Mol Sci"},{"key":"1084_CR18","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s00018-012-1173-4","volume":"70","author":"S Deegan","year":"2013","unstructured":"Deegan S, Saveljeva S, Gorman AM, Samali A. Stress-induced self-cannibalism: on the regulation of autophagy by endoplasmic reticulum stress. Cell Mol Life Sci. 2013;70:2425\u201341. https:\/\/doi.org\/10.1007\/s00018-012-1173-4.","journal-title":"Cell Mol Life Sci"},{"key":"1084_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/prca.201500083","volume":"10","author":"P Del Boccio","year":"2016","unstructured":"Del Boccio P, Rossi C, di Ioia M, Cicalini I, Sacchetta P, Pieragostino D. Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine. Proteomics\u2014Clin Appl. 2016;10:470\u201384. https:\/\/doi.org\/10.1002\/prca.201500083.","journal-title":"Proteomics\u2014Clin Appl"},{"key":"1084_CR20","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(18)31320-5.","journal-title":"Lancet"},{"key":"1084_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-019-0359-2","volume":"19","author":"X Ding","year":"2019","unstructured":"Ding X, Fang C, Li X, Cao YJ, Zhang QL, Huang Y, Pan J, Zhang X. Type 1 diabetes-associated cognitive impairment and diabetic peripheral neuropathy in Chinese adults: Results from a prospective cross-sectional study. BMC Endocr Disord. 2019;19:1\u20136. https:\/\/doi.org\/10.1186\/s12902-019-0359-2.","journal-title":"BMC Endocr Disord"},{"key":"1084_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/intimm\/dxac025","volume":"34","author":"Y Endo","year":"2022","unstructured":"Endo Y, Kanno T, Nakajima T. Fatty acid metabolism in T-cell function and differentiation. Int Immunol. 2022;34:579\u201387. https:\/\/doi.org\/10.1093\/intimm\/dxac025.","journal-title":"Int Immunol"},{"key":"1084_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/J.EJIM.2023.06.020","volume":"116","author":"M Fidalgo","year":"2023","unstructured":"Fidalgo M, Faria R, Carvalho C, Carvalheiras G, Mendon\u00e7a D, Farinha F, da Silva BM, Vasconcelos C. Multiple autoimmune syndrome: clinical, immunological and genotypic characterization. Eur J Intern Med. 2023;116:119\u201330. https:\/\/doi.org\/10.1016\/J.EJIM.2023.06.020.","journal-title":"Eur J Intern Med"},{"key":"1084_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2532108","volume":"2016","author":"L Forga","year":"2016","unstructured":"Forga L, Bolado F, Go\u00f1i MJ, Tamayo I, Ib\u00e1\u00f1ez B, Prieto C. Low serum levels of prealbumin, retinol binding protein, and retinol are frequent in adult type 1 diabetic patients. J Diabetes Res. 2016;2016:1\u20136. https:\/\/doi.org\/10.1155\/2016\/2532108.","journal-title":"J Diabetes Res"},{"key":"1084_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043554","author":"R Galiero","year":"2023","unstructured":"Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M, Di SJ, Epifani R, Piacevole A, Tagliaferri G, Rocco M, Iadicicco I, Docimo G, Rinaldi L, Sardu C, Salvatore T, Marfella R, Sasso FC. Peripheral neuropathy in diabetes mellitus\u202f: pathogenetic mechanisms and diagnostic options. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043554.","journal-title":"Int J Mol Sci"},{"key":"1084_CR26","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1471-4159.2012.07934.x","volume":"123","author":"H Gonzalo","year":"2012","unstructured":"Gonzalo H, Brieva L, Tatzber F, Jov\u00e9 M, Cacabelos D, Cassany\u00e9 A, Lanau-Angulo L, Boada J, Serrano JCE, Gonz\u00e1lez C, Hern\u00e1ndez L, Peralta S, Pamplona R, Portero-Otin M. Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism. J Neurochem. 2012;123:622\u201334. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07934.x.","journal-title":"J Neurochem"},{"key":"1084_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","volume":"10","author":"GA Gregory","year":"2022","unstructured":"Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, Donaghue KC, Magliano DJ, Maniam J, Orchard TJ, Rai P, Ogle GD. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10:741\u201360. https:\/\/doi.org\/10.1016\/S2213-8587(22)00218-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1084_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-0854.2004.00245.x","volume":"6","author":"M Hamasaki","year":"2005","unstructured":"Hamasaki M, Noda T, Baba M, Ohsumi Y. Starvation triggers the delivery of the endoplasmic reticulum to the vacuole via autophagy in yeast. Traffic. 2005;6:56\u201365. https:\/\/doi.org\/10.1111\/j.1600-0854.2004.00245.x.","journal-title":"Traffic"},{"key":"1084_CR29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrendo.2009.216","volume":"5","author":"AE Handel","year":"2009","unstructured":"Handel AE, Handunnetthi L, Ebers GC, Ramagopalan SV. Type 1 diabetes mellitus and multiple sclerosis: common etiological features. Nat Rev Endocrinol. 2009;5:655\u201364. https:\/\/doi.org\/10.1038\/nrendo.2009.216.","journal-title":"Nat Rev Endocrinol"},{"key":"1084_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.536854","author":"Q Hu","year":"2020","unstructured":"Hu Q, Che G, Yang Y, Xie H, Tian J. Histone deacetylase 3 aggravates type 1 diabetes mellitus by inhibiting lymphocyte apoptosis through the microRNA-296\u20135p\/Bcl-xl axis. Front Genet. 2020. https:\/\/doi.org\/10.3389\/fgene.2020.536854.","journal-title":"Front Genet"},{"key":"1084_CR31","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/jdi.12469","volume":"7","author":"J Huang","year":"2016","unstructured":"Huang J, Xiao Y, Xu A, Zhou Z. Neutrophils in type 1 diabetes. J Diabetes Investig. 2016;7:652\u201363. https:\/\/doi.org\/10.1111\/jdi.12469.","journal-title":"J Diabetes Investig"},{"key":"1084_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02648725.2015.1080064","volume":"31","author":"M Jamil","year":"2015","unstructured":"Jamil M, Wang W, Xu M, Tu J. Exploring the roles of basal transcription factor 3 in eukaryotic growth and development. Biotechnol Genet Eng Rev. 2015;31:21\u201345. https:\/\/doi.org\/10.1080\/02648725.2015.1080064.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"1084_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10073","volume":"8","author":"CY Jin","year":"2022","unstructured":"Jin CY, Yu SW, Yin JT, Yuan XY, Wang XG. Corresponding risk factors between cognitive impairment and type 1 diabetes mellitus: a narrative review. Heliyon. 2022;8: e10073. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10073.","journal-title":"Heliyon"},{"key":"1084_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12035-015-9648-6","volume":"54","author":"AP Kallaur","year":"2017","unstructured":"Kallaur AP, Reiche EMV, Oliveira SR, Sim\u00e3o ANC, de Pereira WLCJ, Alfieri DF, Flauzino T, de Proen\u00e7a CM, Lozovoy MAB, Kaimen-Maciel DR, Maes M. Genetic, immune-inflammatory, and oxidative stress biomarkers as predictors for disability and disease progression in multiple sclerosis. Mol Neurobiol. 2017;54:31\u201344. https:\/\/doi.org\/10.1007\/s12035-015-9648-6.","journal-title":"Mol Neurobiol"},{"key":"1084_CR35","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","volume":"585","author":"C Larochelle","year":"2011","unstructured":"Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood\u2013brain barrier in multiple sclerosis? FEBS Lett. 2011;585:3770\u201380. https:\/\/doi.org\/10.1016\/j.febslet.2011.04.066.","journal-title":"FEBS Lett"},{"key":"1084_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann H. Multiple sclerosis pathology. Cold Spring Harb Perspect Med. 2018;8:1\u201316. https:\/\/doi.org\/10.1101\/cshperspect.a028936.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1084_CR37","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1177\/1352458507076406","volume":"13","author":"V Lehmensiek","year":"2007","unstructured":"Lehmensiek V, S\u00fcssmuth SD, Tauscher G, Brettschneider J, Felk S, Gillardon F, Tumani H. Cerebrospinal fluid proteome profile in multiple sclerosis. Mult Scler. 2007;13:840\u20139. https:\/\/doi.org\/10.1177\/1352458507076406.","journal-title":"Mult Scler"},{"key":"1084_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2017.08.002","volume":"36","author":"HN Lemus","year":"2018","unstructured":"Lemus HN, Warrington AE, Rodriguez M. Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair. Neurol Clin. 2018;36:1\u201311. https:\/\/doi.org\/10.1016\/j.ncl.2017.08.002.","journal-title":"Neurol Clin"},{"key":"1084_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","volume":"39","author":"DM Maahs","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39:481\u201397. https:\/\/doi.org\/10.1016\/j.ecl.2010.05.011.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1084_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5114\/ceji.2017.72806","volume":"42","author":"M Malinowska","year":"2017","unstructured":"Malinowska M, Tokarz-Deptula B, Deptula W. Butyrophilins: an important new element of resistance. Cent Eur J Immunol. 2017;42:399\u2013403. https:\/\/doi.org\/10.5114\/ceji.2017.72806.","journal-title":"Cent Eur J Immunol"},{"key":"1084_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2011.12.026","volume":"244","author":"I Mandel","year":"2012","unstructured":"Mandel I, Paperna T, Miller A. Aberrant expression of the apoptosis-related proteins BAK and MCL1 in T cells in multiple sclerosis. J Neuroimmunol. 2012;244:51\u20136. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.12.026.","journal-title":"J Neuroimmunol"},{"key":"1084_CR42","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1210\/en.2017-03273","volume":"159","author":"MR Marasco","year":"2018","unstructured":"Marasco MR, Linnemann AK. \u03b2-cell autophagy in diabetes pathogenesis. Endocrinology. 2018;159:2127\u201341. https:\/\/doi.org\/10.1210\/en.2017-03273.","journal-title":"Endocrinology"},{"key":"1084_CR43","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(02)08431-3","volume":"359","author":"MG Marrosu","year":"2002","unstructured":"Marrosu MG, Cocco E, Lai M, Spinicci G, Pischedda MP, Contu P. Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet. 2002;359:1461\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(02)08431-3.","journal-title":"Lancet"},{"key":"1084_CR44","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1042\/BST20190331","volume":"47","author":"GR Masson","year":"2019","unstructured":"Masson GR. Towards a model of GCN2 activation. Biochem Soc Trans. 2019;47:1481\u20138. https:\/\/doi.org\/10.1042\/BST20190331.","journal-title":"Biochem Soc Trans"},{"key":"1084_CR45","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ecl.2010.05.009","volume":"39","author":"LY Melendez-Ramirez","year":"2010","unstructured":"Melendez-Ramirez LY, Richards RJ, Cefalu WT. Complications of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39:625\u201340. https:\/\/doi.org\/10.1016\/j.ecl.2010.05.009.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1084_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.603710","author":"C Misrielal","year":"2020","unstructured":"Misrielal C, Mauthe M, Reggiori F, Eggen BJL. Autophagy in multiple sclerosis: two sides of the same coin. Front Cell Neurosci. 2020. https:\/\/doi.org\/10.3389\/fncel.2020.603710.","journal-title":"Front Cell Neurosci"},{"key":"1084_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1590\/1414-431X2023E12776","volume":"3","author":"S Mungan","year":"2023","unstructured":"Mungan S, Guzel I, Demirdogen BC. Association between expanded disability status scale score and dietary antioxidant capacity in patients with multiple sclerosis. Braz J Med Biol Res = Rev Bras Pesqui Medicas e Biol. 2023;3:5. https:\/\/doi.org\/10.1590\/1414-431X2023E12776.","journal-title":"Braz J Med Biol Res = Rev Bras Pesqui Medicas e Biol"},{"key":"1084_CR48","doi-asserted-by":"publisher","first-page":"108267","DOI":"10.1016\/j.jdiacomp.2022.108267","volume":"36","author":"JA Muthulingam","year":"2022","unstructured":"Muthulingam JA, Brock C, Hansen TM, Drewes AM, Brock B, Fr\u00f8kj\u00e6r JB. Disrupted white matter integrity in the brain of type 1 diabetes is associated with peripheral neuropathy and abnormal brain metabolites. J Diabetes Complications. 2022;36:108267. https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108267.","journal-title":"J Diabetes Complications"},{"key":"1084_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036245","volume":"102","author":"EI Obeagu","year":"2023","unstructured":"Obeagu EI, Obeagu GU. Type 1 diabetes mellitus: roles of neutrophils in the pathogenesis. Medicine. 2023;102: e36245. https:\/\/doi.org\/10.1097\/MD.0000000000036245.","journal-title":"Medicine"},{"key":"1084_CR50","doi-asserted-by":"publisher","first-page":"175628642412843","DOI":"10.1177\/17562864241284372","volume":"17","author":"C Oreja-Guevara","year":"2024","unstructured":"Oreja-Guevara C, Mart\u00ednez-Y\u00e9lamos S, Eichau S, Llaneza M\u00c1, Mart\u00edn-Mart\u00ednez J, Pe\u00f1a-Mart\u00ednez J, Meca-Lallana V, Alonso-Torres AM, Moral-Torres E, R\u00edo J, Calles C, Ares-Luque A, Rami\u00f3-Torrent\u00e0 L, Marzo-Sola ME, Prieto JM, Mart\u00ednez-Gin\u00e9s ML, Arroyo R, Otano-Mart\u00ednez M\u00c1, Brieva-Ruiz L, G\u00f3mez-Guti\u00e9rrez M, Rodr\u00edguez-Antig\u00fcedad A, Gal\u00e1n S\u00e1nchez-Seco V, Costa-Frossard L, Hern\u00e1ndez-P\u00e9rez M\u00c1, Landete-Pascual L, Gonz\u00e1lez-Platas M, Meca-Lallana JE. Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management. Ther Adv Neurol Disord. 2024;17:17562864241284372. https:\/\/doi.org\/10.1177\/17562864241284372.","journal-title":"Ther Adv Neurol Disord"},{"key":"1084_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEULET.2021.136287","author":"M Pagnin","year":"2022","unstructured":"Pagnin M, Dekiwadia C, Petratos S, Richardson SJ. Enhanced re-myelination in transthyretin null mice following cuprizone mediated demyelination. Neurosci Lett. 2022. https:\/\/doi.org\/10.1016\/J.NEULET.2021.136287.","journal-title":"Neurosci Lett"},{"key":"1084_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013775.pub2","author":"J Perais","year":"2023","unstructured":"Perais J, Agarwal R, Evans JR, Loveman E, Colquitt JL, Owens D, Hogg RE, Lawrenson JG, Takwoingi Y, Lois N. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. Cochrane Database Syst Rev. 2023. https:\/\/doi.org\/10.1002\/14651858.CD013775.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1084_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0283698","volume":"18","author":"G P\u00f6ll","year":"2023","unstructured":"P\u00f6ll G, Griesenbeck J, Tschochner H, Milkereit P. Impact of the yeast S0\/uS2-cluster ribosomal protein rpS21\/eS21 on rRNA folding and the architecture of small ribosomal subunit precursors. PLoS ONE. 2023;18:1\u201321. https:\/\/doi.org\/10.1371\/journal.pone.0283698.","journal-title":"PLoS ONE"},{"key":"1084_CR54","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302. https:\/\/doi.org\/10.1002\/ana.22366.","journal-title":"Ann Neurol"},{"key":"1084_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.869197","volume":"13","author":"SL Pompura","year":"2022","unstructured":"Pompura SL, Hafler DA, Dominguez-Villar M. Fatty acid metabolism and T cells in multiple sclerosis. Front Immunol. 2022;13:1\u201315. https:\/\/doi.org\/10.3389\/fimmu.2022.869197.","journal-title":"Front Immunol"},{"key":"1084_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dmrr.3505","volume":"38","author":"V Pozzilli","year":"2022","unstructured":"Pozzilli V, Grasso EA, Tomassini V. Similarities and differences between multiple sclerosis and type 1 diabetes. Diabetes Metab Res Rev. 2022;38:1\u20135. https:\/\/doi.org\/10.1002\/dmrr.3505.","journal-title":"Diabetes Metab Res Rev"},{"key":"1084_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011112","author":"MG Rispoli","year":"2021","unstructured":"Rispoli MG, Valentinuzzi S, De Luca G, Del Boccio P, Federici L, Di Ioia M, Digiovanni A, Grasso EA, Pozzilli V, Villani A, Chiarelli AM, Onofrj M, Wise RG, Pieragostino D, Tomassini V. Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222011112.","journal-title":"Int J Mol Sci"},{"key":"1084_CR58","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00281-019-00765-0","volume":"41","author":"F Ruiz","year":"2019","unstructured":"Ruiz F, Vigne S, Pot C. Resolution of inflammation during multiple sclerosis. Semin Immunopathol. 2019;41:711\u201326. https:\/\/doi.org\/10.1007\/s00281-019-00765-0.","journal-title":"Semin Immunopathol"},{"key":"1084_CR59","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/1753-0407.12483","volume":"9","author":"N Safari-Alighiarloo","year":"2017","unstructured":"Safari-Alighiarloo N, Taghizadeh M, Tabatabaei SM, Shahsavari S, Namaki S, Khodakarim S, Rezaei-Tavirani M. Identification of new key genes for type 1 diabetes through construction and analysis of protein\u2013protein interaction networks based on blood and pancreatic islet transcriptomes. J Diabetes. 2017;9:764\u201377. https:\/\/doi.org\/10.1111\/1753-0407.12483.","journal-title":"J Diabetes"},{"key":"1084_CR60","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.cmet.2011.04.004","volume":"13","author":"R Singh","year":"2011","unstructured":"Singh R, Cuervo AM. Autophagy in the cellular energetic balance. Cell Metab. 2011;13:495\u2013504. https:\/\/doi.org\/10.1016\/j.cmet.2011.04.004.","journal-title":"Cell Metab"},{"key":"1084_CR61","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10792-021-02088-2","volume":"42","author":"W Sun","year":"2022","unstructured":"Sun W, Shi Y, Yang J, Song X, Zhang Y, Zhang W, Zhou X. Transthyretin and retinol-binding protein as discriminators of diabetic retinopathy in type 1 diabetes mellitus. Int Ophthalmol. 2022;42:1041\u20139. https:\/\/doi.org\/10.1007\/s10792-021-02088-2.","journal-title":"Int Ophthalmol"},{"key":"1084_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1259\/bjr.20150680","volume":"89","author":"H Toprak","year":"2016","unstructured":"Toprak H, Yetis H, Alkan A, Filiz M, Kurtcan S, Aralasmak A, Saksu M, Cesur Y. Relationships of DTI findings with neurocognitive dysfunction in children with type 1 diabetes mellitus. Br J Radiol. 2016;89:11\u20135. https:\/\/doi.org\/10.1259\/bjr.20150680.","journal-title":"Br J Radiol"},{"key":"1084_CR63","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/NMETH.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J. The perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731\u201340. https:\/\/doi.org\/10.1038\/NMETH.3901.","journal-title":"Nat Methods"},{"key":"1084_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/561262","volume":"2011","author":"E Tynyakov-Samra","year":"2011","unstructured":"Tynyakov-Samra E, Auriel E, Levy-Amir Y, Karni A. Reduced ErbB4 expression in immune cells of patients with relapsing remitting multiple sclerosis. Mult Scler Int. 2011;2011:1\u20137. https:\/\/doi.org\/10.1155\/2011\/561262.","journal-title":"Mult Scler Int"},{"key":"1084_CR65","doi-asserted-by":"publisher","first-page":"105313","DOI":"10.1016\/j.neuint.2022.105313","volume":"155","author":"M Ueda","year":"2022","unstructured":"Ueda M. Transthyretin: its function and amyloid formation. Neurochem Int. 2022;155:105313. https:\/\/doi.org\/10.1016\/j.neuint.2022.105313.","journal-title":"Neurochem Int"},{"key":"1084_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00003.2010","volume":"91","author":"TL Van Belle","year":"2011","unstructured":"Van Belle TL, Coppieters KT, Von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev. 2011;91:79\u2013118. https:\/\/doi.org\/10.1152\/physrev.00003.2010.","journal-title":"Physiol Rev"},{"key":"1084_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-017-1697-7","volume":"134","author":"R van den Berg","year":"2017","unstructured":"van den Berg R, Hoogenraad CC, Hintzen RQ. Axonal transport deficits in multiple sclerosis: spiraling into the abyss. Acta Neuropathol. 2017;134:1\u201314. https:\/\/doi.org\/10.1007\/s00401-017-1697-7.","journal-title":"Acta Neuropathol"},{"key":"1084_CR68","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1007\/s00125-017-4403-3","volume":"60","author":"KM van Megen","year":"2017","unstructured":"van Megen KM, Spindler MP, Keij FM, Bosch I, Sprangers F, van Royen-Kerkhof A, Nikolic T, Roep BO. Relapsing\/remitting type 1 diabetes. Diabetologia. 2017;60:2252\u20135. https:\/\/doi.org\/10.1007\/s00125-017-4403-3.","journal-title":"Diabetologia"},{"key":"1084_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/biom13121696","author":"A Villoria-Gonz\u00e1lez","year":"2023","unstructured":"Villoria-Gonz\u00e1lez A, Zierfuss B, Parzer P, Heub\u00f6ck E, Zujovic V, Waidhofer-S\u00f6llner P, Ponleitner M, Rommer P, G\u00f6pfert J, Forss-Petter S, Berger J, Weinhofer I. Efficacy of HDAC inhibitors in driving peroxisomal \u03b2-oxidation and immune responses in human macrophages: implications for neuroinflammatory disorders. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13121696.","journal-title":"Biomolecules"},{"key":"1084_CR70","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nri2192","volume":"7","author":"M von Herrath","year":"2007","unstructured":"von Herrath M, Sanda S, Herold K. Type 1 diabetes as a relapsing\u2013remitting disease? Nat Rev Immunol. 2007;7:988\u201394. https:\/\/doi.org\/10.1038\/nri2192.","journal-title":"Nat Rev Immunol"},{"key":"1084_CR71","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler J. 2020;26:1816\u201321. https:\/\/doi.org\/10.1177\/1352458520970841.","journal-title":"Mult Scler J"},{"key":"1084_CR72","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.2147\/CMAR.S246928","volume":"12","author":"T Wang","year":"2020","unstructured":"Wang T, Wang ZY, Zeng LY, Gao YZ, Yan YX, Zhang Q. Down-regulation of ribosomal protein RPS21 inhibits invasive behavior of osteosarcoma cells through the inactivation of MAPK pathway. Cancer Manag Res. 2020;12:4949\u201355. https:\/\/doi.org\/10.2147\/CMAR.S246928.","journal-title":"Cancer Manag Res"},{"key":"1084_CR73","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.4049\/jimmunol.166.4.2831","volume":"166","author":"S Winer","year":"2001","unstructured":"Winer S, Astsaturov I, Cheung RK, Gunaratnam L, Kubiak V, Cortez MA, Moscarello M, O\u2019Connor PW, McKerlie C, Becker DJ, Dosch H-M. Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis. J Immunol. 2001;166:2831\u201341. https:\/\/doi.org\/10.4049\/jimmunol.166.4.2831.","journal-title":"J Immunol"},{"key":"1084_CR74","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/NMETH.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359\u201362. https:\/\/doi.org\/10.1038\/NMETH.1322.","journal-title":"Nat Methods"},{"key":"1084_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/mcp.M111.012203","volume":"10","author":"W Zhi","year":"2011","unstructured":"Zhi W, Sharma A, Purohit S, Miller E, Bode B, Anderson SW, Reed JC, Steed RD, Steed L, Hopkins D, She JX. Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays. Mol Cell Proteomics. 2011;10:1\u201310. https:\/\/doi.org\/10.1074\/mcp.M111.012203.","journal-title":"Mol Cell Proteomics"},{"key":"1084_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/gene.2008.84","volume":"10","author":"M Zoledziewska","year":"2009","unstructured":"Zoledziewska M, Costa G, Pitzalis M, Cocco E, Melis C, Moi L, Zavattari P, Murru R, Lampis R, Morelli L, Poddie F, Frongia P, Pusceddu P, Bajorek M, Marras A, Satta AM, Chessa A, Pugliatti M, Sotgiu S, Whalen MB, Rosati G, Cucca F, Marrosu MG. Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun. 2009;10:15\u20137. https:\/\/doi.org\/10.1038\/gene.2008.84.","journal-title":"Genes Immun"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01084-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T04:28:47Z","timestamp":1738556927000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01084-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01084-x","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this study was evaluated by an ethics committee. In the case of T1DM individuals, the protocol received approval from the Biomedical Research Ethics Committee of C\u00e1diz (Reference: 04-abr-PI22-01718) and for MS participants the Andalusian Biomedical Research Ethics Committee (Reference: LFD-VIT-2018-01). Before being enrolled in the study, all the individuals, both patients and healthy volunteers, were fully informed and provided written consent to participate in the research, following the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}